Proteomic analysis of the cerebrospinal fluid of patients with restless legs syndrome/Willis-Ekbom disease. [PDF]
Patton SM +5 more
europepmc +1 more source
The relationship among restless legs syndrome (Willis-Ekbom Disease), hypertension, cardiovascular disease, and cerebrovascular disease. [PDF]
Ferini-Strambi L, Walters AS, Sica D.
europepmc +1 more source
Effect of Cannabinoids use on Symptoms of Restless Leg Syndrome among Adults: A Scoping Review. [PDF]
Saha S +4 more
europepmc +1 more source
Validation of the Multiple Suggested Immobilization Test: A Test for the Assessment of Severity of Restless Legs Syndrome (Willis-Ekbom Disease). [PDF]
Garcia-Borreguero D +5 more
europepmc +1 more source
Gabapentin enacarbil for the treatment of moderate to severe primary restless legs syndrome (Willis-Ekbom disease): 600 or 1,200 mg dose? [PDF]
Kume A.
europepmc +1 more source
Post Hoc Analysis of Data from Two Clinical Trials Evaluating the Minimal Clinically Important Change in International Restless Legs Syndrome Sum Score in Patients with Restless Legs Syndrome (Willis-Ekbom Disease). [PDF]
Ondo WG +4 more
europepmc +1 more source
Mouse Model for Protein Tyrosine Phosphatase D (<i>PTPRD</i>) Associations with Restless Leg Syndrome or Willis-Ekbom Disease and Addiction: Reduced Expression Alters Locomotion, Sleep Behaviors and Cocaine-Conditioned Place Preference. [PDF]
Drgonova J +8 more
europepmc +1 more source
Limitations in the study of restless legs syndrome and ferritin levels in older adults with dementia. [PDF]
Gul A, Gul R.
europepmc +1 more source
Painful Willis-Ekbom disease: unbearable and distinct form of restless legs?
openaire +2 more sources

